How Does Haemonetics Co. (NYSE:HAE) Maintain Its Market Position

2 min read | February 21, 2025 12:00 AM PST | By Team Kalkine Media

How Does Haemonetics Co. (NYSE:HAE) Maintain Its Market Position — Image source: Shutterstock

Institutional Investment Adjustments

Haemonetics Co. (NYSE:HAE) has drawn increasing attention from institutional investors, with several financial firms modifying their stakes. Empowered Funds LLC secured a notable position in the fourth quarter, reinforcing market engagement. Other institutional participants, such as Riverwater Partners LLC, significantly expanded their holdings, reflecting continued strategic adjustments in the sector.

Further movements included a 3% stake increase by Keene & Associates Inc., while CWC Advisors LLC entered with a newly established position. Boston Trust Walden Corp raised its stake by 13.8%, accumulating a substantial portfolio share, while the State of Alaska Department of Revenue expanded its investment by 7.3%.

Stock Performance and Market Indicators

Haemonetics Co.’s stock opened at $63.36 in recent trading sessions, aligning with its structured financial position. The company maintains a market capitalization of $3.18 billion, reflecting stable market engagement. Key financial ratios highlight its structured balance sheet, including a debt-to-equity ratio of 1.35, a quick ratio of 2.55, and a current ratio of 3.97.

The company’s stock performance has exhibited a trading range between $58.80 and $97.97 over the past year. This structured fluctuation underscores market adaptability while positioning the company within a defined financial scope.

Industry Presence and Business Operations

Haemonetics Co. operates within the healthcare and medical instruments sector, delivering specialized solutions to global markets. The company’s portfolio includes automated plasma collection systems and integrated software tools designed for optimized healthcare operations.

By maintaining a structured approach to service delivery, Haemonetics Co. continues to expand its operational footprint, contributing to advancements in medical technologies and healthcare solutions.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.